← back to search

Lili Cheng

Zhejiang University · CN
Area of research
Atomic and Molecular Physics, and Optics · Condensed Matter Physics
Research interest
Research interests include Magnetic properties of thin films, Physics of Superconductivity and Magnetism, Angiogenesis and VEGF in Cancer, and Axon Guidance and Neuronal Signaling.
h-index
34
citations
4,355
works
114
NIH funding
primary concept
Chemistry
email

Recent publications

Sulforaphane as a Multi-Scale Mechano-Modulator in Cancer: An Integrative Perspective.
2026cited by 0position: contributordoi
Molecular basis of human taurine transporter uptake and inhibition.
2025cited by 3position: contributordoi
Structure and transport mechanism of human riboflavin transporters.
2025cited by 3position: contributordoi
Slc22a17 governs postnatal neurogenesis by maintaining the iron homeostasis in hippocampus.
2025cited by 0position: contributordoi
Hepatic mitochondrial NAD+ transporter SLC25A47 activates AMPKα mediating lipid metabolism and tumorigenesis
Hepatology 2023cited by 63position: contributordoi
Ablation of Proton/Glucose Exporter SLC45A2 Enhances Melanosomal Glycolysis to Inhibit Melanin Biosynthesis and Promote Melanoma Metastasis
Journal of Investigative Dermatology 2022cited by 23position: contributordoi
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19.
2021cited by 136position: contributordoi
SLC22A14 is a mitochondrial riboflavin transporter required for sperm oxidative phosphorylation and male fertility.
2021cited by 73position: contributordoi
Downregulated miR-1271-5p inhibits proliferation and invasion of trophoblast cells by activates Grhl2/CHL1 axis in preeclampsia
Research Square 2021cited by 0position: middledoi
Organic cation transporter 3 (Oct3) is a distinct catecholamines clearance route in adipocytes mediating the beiging of white adipose tissue
PLoS Biology 2019cited by 54position: middledoi
Organic cation transporter 3 (Oct3) is a distinct catecholamines clearance route in adipocytes mediating the beiging of white adipose tissue.
2019cited by 46position: contributordoi
mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis.
2019cited by 27position: contributordoi
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis
Hepatology 2017cited by 194position: middledoi
Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment
Biomedicine & Pharmacotherapy 2016cited by 18position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ligong Chen · Hebei Agricultural University9 papers (2017–2025) · 7 papers (2019–2025) · 5 papers (2022–2025) · 2 papers (2022–2023) · 2 papers (2022–2023)Hao Fan · Xi'an Jiaotong University2 papers (2022–2023) · 2 papers (2022–2023) · 2 papers (2022–2023)Yuedong Huang · Yale Cancer Center2 papers (2017–2019)Meixiang Sang · Shanghai University of Electric Power1 papers (2016–2016)Lijun Qin · Guizhou University1 papers (2016–2016)Jiandie D. Lin · Ann Arbor Center for Independent Living1 papers (2023–2023)Kun Sun · Tsinghua University1 papers (2017–2017) · 1 papers (2017–2017)Kathleen M. Giacomini · University of California, San Francisco1 papers (2019–2019)Zengqiang Yuan · Chinese Institute for Brain Research1 papers (2025–2025)Ziyi Meng · Xinjiang Agricultural University1 papers (2019–2019)Zhilong Ma · Shanghai Medical College of Fudan University1 papers (2019–2019)Baoen Shan · Hebei Medical University1 papers (2016–2016)Diego F. Calvisi · University of Sassari1 papers (2017–2017)